Pre-order Enquiry
Request Free Sample
Global Infectious Disease Therapeutics Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15848521 | Publishing Date : 24-Jun-2020 | No. of pages : 90
Request Sample
Request Customization
Check Discounts
Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.
Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of infectious diseases, escalating consumption of anti-microbial direct acting drugs, growing geriatric population, rising awareness among population, upsurge in government investment into healthcare to eradicate infectious diseases.
Market Analysis and Insights: Global Infectious Disease Therapeutics Market
The global Infectious Disease Therapeutics market size is projected to reach US$ 47580 million by 2026, from US$ 45730 million in 2020, at a CAGR of 3.7%% during 2021-2026.
Global Infectious Disease Therapeutics Scope and Market Size
Infectious Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Novartis AG
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
BioCryst Pharmaceuticals Inc.
Merck & Co. Inc.
Boehringer Ingelheim GmbH
Drugs
Vaccines
HIV/AIDS
Influenza
Hepatitis
Malaria
Tuberculosis
Others
North America
Europe
China
Japan
Southeast Asia
India
Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of infectious diseases, escalating consumption of anti-microbial direct acting drugs, growing geriatric population, rising awareness among population, upsurge in government investment into healthcare to eradicate infectious diseases.
Market Analysis and Insights: Global Infectious Disease Therapeutics Market
The global Infectious Disease Therapeutics market size is projected to reach US$ 47580 million by 2026, from US$ 45730 million in 2020, at a CAGR of 3.7%% during 2021-2026.
Global Infectious Disease Therapeutics Scope and Market Size
Infectious Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis AG
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
BioCryst Pharmaceuticals Inc.
Merck & Co. Inc.
Boehringer Ingelheim GmbH
Market segment by Type, the product can be split into
Drugs
Vaccines
Market segment by Application, split into
HIV/AIDS
Influenza
Hepatitis
Malaria
Tuberculosis
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
